Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity - Wikidata - wikimedia - TriplyDB

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

http://www.wikidata.org/entity/Q37596441

about

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency MX2 is an interferon-induced inhibitor of HIV-1 infection Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent The cyclophilins HIV-1 capsid: the multifaceted key player in HIV-1 infection Time-Resolved Imaging of Single HIV-1 Uncoating In Vitro and in Living Cells Cyclophilin A stabilizes the HIV-1 capsid through a novel non-canonical binding site.Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication Acetylation regulates Cyclophilin A catalysis, immunosuppression and HIV isomerization HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358 The overlap of small molecule and protein binding sites within families of protein structures Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection Target cell cyclophilins facilitate human papillomavirus type 16 infection Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways Gene expression analysis of a panel of cell lines that differentially restrict HIV-1 CA mutants infection in a cyclophilin a-dependent manner Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175 Evolution of a TRIM5-CypA splice isoform in old world monkeys SIV replication in human cells Cellular proteins in influenza virus particles Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Retroviral restriction factor TRIM5alpha is a trimer Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen.Extreme genetic fragility of the HIV-1 capsid.The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid.Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection Host cell species-specific effect of cyclosporine A on simian immunodeficiency virus replication.Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection.Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.

P2860

Q24300016-8321E518-4D28-48C9-8749-A9496DD04780 Q24338311-2615BE52-4323-4485-9D19-3D266B5926A2 Q24536359-B764B406-B138-4560-90F7-1BB81C80A47B Q24543218-880D67A4-C54A-407E-953B-D6E00B747562 Q24656023-6BA1DA62-F40B-4A0F-9A51-22BDAB73E0AA Q24812580-1C58D5B3-B29D-4724-985A-3B26655B329E Q26801145-0F8BEAC0-E9DE-4036-83CA-F9EAE9CB73C7 Q27313409-63FD1F31-9CFB-4195-A1EB-9E915C9EBBDA Q27332017-D1B14C3A-6EA7-47C9-939A-1120C7248CB4 Q27473218-E302E72A-E7E6-45BC-B0DF-C923985F18F6 Q27480361-29F295FB-6C09-4C5C-AE25-2E8DB8F7C4EC Q27488788-503E5181-67E9-4238-BF4A-E1A22DF9BFD0 Q27489053-8F484715-55F1-4FF4-8B0B-FD09C61989E6 Q27660416-20166726-0E17-4DC9-B613-6B66733028FC Q27679304-BAE577B6-C0B6-46DD-B388-82792E80948D Q28472769-7BC10EF2-AB92-41DF-97F0-9E04C6D6F7B9 Q28474342-AEBFE8D4-B4F0-4331-9EAF-495192A52883 Q28475787-B44DC7EB-6316-4B19-A915-92656EC143D9 Q28483731-A5EF5980-51AD-485C-8089-E29E56A0B2FC Q28541423-FE3E2818-E063-4EE9-8142-B62A9E9B5D43 Q28546614-DED7F191-64DE-4932-962C-260A16C0CDEF Q28551538-9AA28AFF-D383-4997-8CD0-933F5D16F5B0 Q28755216-1181278A-7DA5-43B5-AA95-8B5CE9E3E813 Q30417737-C46CD4D6-9E97-4FCF-A9EC-04E7F45E554B Q33340974-9D48B263-B595-4793-8B85-F69779109B0D Q33725558-5D6BAB7E-1F40-4619-9028-FFA18998E3D4 Q33826603-329923BB-BF19-46C8-BBEE-0E2285FC4685 Q33826918-FB760222-3B88-4FC5-81B8-621BA242DA98 Q34123929-6EB45C3E-6AC0-42FC-985B-E12A89600286 Q34262274-E3778F7C-1B55-40C7-9091-DCE80DCCA920 Q34301892-03E69AC5-C5AD-426C-9A2D-766AA691593F Q34434872-CA2887F4-6302-469A-807B-34F46ACB6915 Q34542419-2A251E92-5184-4C3E-90DD-DFD1E87220F7 Q34789351-FF36A6B4-1C18-43EB-9697-28D6995E94EA Q35140243-5C9A317E-463E-4B5F-B664-0455C3494B81 Q35487739-6EDEA5C7-3E94-4E2A-B7F4-9AD370E7EDF2 Q35635089-825546B1-7C9E-4428-9598-7EC969004173 Q35850448-C515EFB7-271E-42EA-AFBB-09E7C35B0AC6 Q35868118-28EC7227-E2CA-4E68-9239-608647CE999C Q35947645-431CBA9E-42FA-4971-B76C-CA78F9EF81DC

P2860

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

http://www.wikidata.org/entity/Q37596441

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

@en

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

@nl

type

label

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

@en

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

@nl

prefLabel

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

@en

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

@nl

P1433

Q37596441-6AEE2D3E-8EE4-4FFE-BDCA-37B72F0753FF

P1476

Q37596441-4696EA74-8646-490C-AE09-E171D822C401

P2093

Q37596441-BB4B0D60-14AD-4247-AED3-6FB20C7BFED6

P2860

Q37596441-01774911-7897-4884-B7B9-A909FCC2F2AD

Q37596441-0976456F-AD35-43DA-B118-F2173175716B

Q37596441-0EABDDB5-BE4D-4D89-8122-1D5515ED983D

Q37596441-0F5A482C-3D16-4D87-B8D5-CD6F990DC740

Q37596441-101A59E2-5840-4BEB-AC10-AEA297463917

Q37596441-1441F369-DB3B-47CE-B3F5-7FAF5D5AB74E

Q37596441-150C81A1-A358-4108-B55A-085B4B348610

Q37596441-18E0078D-62F5-4060-8B4D-6CCFA931762A

Q37596441-1974B355-E5AC-47D1-AE2D-EC48BD42277D

Q37596441-38EFBC54-C474-4EB6-B818-79BC1D54078E

P304

Q37596441-284CDE7D-2A3D-4852-82DA-28677222BCB4

P31

Q37596441-AAA34D92-3CE2-4253-9ADF-01778271E13C

P356

Q37596441-97106884-0FE7-401E-831A-7969D123B901

P407

Q37596441-1C158B7D-90E9-4CCD-9227-2CA860E6F59E

P433

Q37596441-EE0BB3C5-0D3D-47C8-8482-319F7DB55C48

P478

Q37596441-F666D1D2-99BE-49D8-A7E7-ADA069A8433B

P50

Q37596441-2CC4982C-C5BC-4CA8-A0BF-0B8B11EF760D

Q37596441-5EF606DE-57E7-49A8-B91A-AD201BD89790

P577

Q37596441-1712AD3F-343E-4436-8B0A-765A5FB8C59C

P698

Q37596441-D6269D33-8C30-40F1-82C6-F7EEABA2651B

P932

Q37596441-37A196C2-9528-4439-B1DD-A8B4622D958C

P356

JVI.78.23.12800-12808.2004

P1433

Journal of Virology

P1476

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

@en

P2093

Elena Sokolskaja

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells

Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA

The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein

Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein

Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid

Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity

A system for stable expression of short interfering RNAs in mammalian cells

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A

P304

12800-12808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.78.23.12800-12808.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15542632

http://www.w3.org/2001/XMLSchema#string

P932

524981

http://www.w3.org/2001/XMLSchema#string